Literature DB >> 24861481

Breast conserving therapy for DCIS--does size matter?

Olga Kantor1, David J Winchester.   

Abstract

The incidence of ductal carcinoma in situ has increased dramatically with the use of screening mammography. Most patients can be considered for breast conserving therapy, depending upon patient and pathologic variables. In addition to other factors, tumor size is important to provide proper patient selection for breast conserving surgery and predict risk of local recurrence.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  breast-conserving surgery; local recurrence; mammography

Mesh:

Year:  2014        PMID: 24861481     DOI: 10.1002/jso.23657

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  3 in total

1.  Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients.

Authors:  M J Cambra; F Moreno; X Sanz; L Anglada; M Mollà; V Reyes; M Arenas; A Pedro; R Ballester; V García; J Casals; M Cusidó; C Jimenez; J M Escribà; M Macià; J M Solé; A Arcusa; M A Seguí; S Gonzalez; B Farrús; A Biete
Journal:  Clin Transl Oncol       Date:  2019-07-01       Impact factor: 3.405

2.  Polygon method: A systematic margin assessment for breast conservation.

Authors:  Shu Ichihara; Suzuko Moritani; Rieko Nishimura; Mikinao Oiwa; Takako Morita; Takako Hayashi; Aya Kato; Tokiko Endo; Akiko Kada; Noriko Ito; Tetsuo Kuroishi; Yasuyuki Sato
Journal:  Cancer Med       Date:  2019-05-07       Impact factor: 4.452

3.  Breast-conserving therapy versus mastectomy for breast cancer: a ten-year follow-up single-center real-world study.

Authors:  Wanheng Li; Yiqiong Zheng; Huan Wu; Xiru Li
Journal:  Gland Surg       Date:  2022-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.